Chemoinformaics analysis of 1-O-Deacetylohchinolide B
| Molecular Weight | 582.69 | nRot | 4 |
| Heavy Atom Molecular Weight | 540.354 | nRig | 33 |
| Exact Molecular Weight | 582.283 | nRing | 6 |
| Solubility: LogS | -4.638 | nHRing | 3 |
| Solubility: LogP | 3.203 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 5 |
| nHA | 9 | APOL | 90.3333 |
| nHD | 1 | BPOL | 53.4187 |
| QED | 0.234 |
| Synth | 5.634 |
| Natural Product Likeliness | 3.547 |
| NR-PPAR-gamma | 0.949 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.997 |
| HIA | 0.24 |
| CACO-2 | -5.039 |
| MDCK | 0.0000548 |
| BBB | 0.924 |
| PPB | 0.942566 |
| VDSS | 2.996 |
| FU | 0.0613074 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.128 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.559 |
| CYP2c9-inh | 0.466 |
| CYP2c9-sub | 0.068 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.131 |
| CYP3a4-inh | 0.722 |
| CYP3a4-sub | 0.732 |
| CL | 13.675 |
| T12 | 0.026 |
| hERG | 0.042 |
| Ames | 0.015 |
| ROA | 0.92 |
| SkinSen | 0.024 |
| Carcinogencity | 0.035 |
| EI | 0.01 |
| Respiratory | 0.966 |
| NR-Aromatase | 0.638 |
| Antiviral | Yes |
| Prediction | 0.806907 |